What Pharma Cos. Must Know About FDA Off-Label Guidance
The U.S. Food and Drug Administration issued a much-awaited draft guidance on Oct. 24 revising its approach to the dissemination of scientific information on unapproved uses of approved or cleared medical products....To view the full article, register now.
Already a subscriber? Click here to view full article